Insulet Corp (PODD)

Jan 13, 2025, 4:01 PM EST - 4 days ago

Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe

Jan 10, 2025, 6:00 AM EST - 7 days ago

Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Dec 27, 2024, 3:47 PM EST - 21 days ago

Heavy Interest in Insulet's Insulin Delivery Device

Dec 5, 2024, 11:05 AM EST - 6 weeks ago

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case

Dec 4, 2024, 4:28 PM EST - 6 weeks ago

Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court

Nov 20, 2024, 6:26 PM EST - 2 months ago

Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines

Nov 20, 2024, 8:30 AM EST - 2 months ago

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.

Nov 15, 2024, 6:00 AM EST - 2 months ago

Insulet to Present at Upcoming Investor Conferences

Nov 11, 2024, 4:59 PM EST - 2 months ago

Insulet CEO on earnings, GLP-1 and election impact

Nov 11, 2024, 9:42 AM EST - 2 months ago

Buy, Sell, Or Hold Insulet (PODD) Stock?

Nov 11, 2024, 6:18 AM EST - 2 months ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB QDEL

Nov 7, 2024, 10:54 PM EST - 2 months ago

Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 5:44 PM EST - 2 months ago

Insulet raises annual revenue forecast on strong demand for insulin pumps

Nov 7, 2024, 4:01 PM EST - 2 months ago

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)

Nov 1, 2024, 6:00 AM EDT - 2 months ago

Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November

Oct 29, 2024, 4:01 PM EDT - 2 months ago

Omnipod® 5 App for iPhone® Now Fully Available in the United States

Oct 10, 2024, 9:00 AM EDT - 3 months ago

National Campaign Launches to Combat Diabetes Stigma Using Comedy

Sep 30, 2024, 6:00 AM EDT - 3 months ago

Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024

Sep 12, 2024, 7:44 AM EDT - 4 months ago

Upstart, Insulet And 2 Other Stocks Executives Are Selling

UPST INTU Z

Aug 30, 2024, 9:00 AM EDT - 5 months ago

What Helped Insulet Stock Gain 10% This Week?

Aug 27, 2024, 6:35 PM EDT - 5 months ago

S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index

RMD

Aug 27, 2024, 11:32 AM EDT - 5 months ago

This Healthcare Stock Is the Best Performer in the S&P 500 Tuesday

Aug 26, 2024, 4:20 PM EDT - 5 months ago

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

Aug 20, 2024, 5:52 PM EDT - 5 months ago

These Two Stocks Plunged After Eli Lilly Drug Study Showed Diabetes Promise

DXCM

Aug 14, 2024, 3:00 AM EDT - 5 months ago

Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia

Aug 9, 2024, 5:51 PM EDT - 5 months ago

Insulin Pump Maker Insulet's Stock Slumps on User Growth Concerns

Aug 9, 2024, 1:19 PM EDT - 5 months ago

Insulet Is the Worst Stock in S&P 500 Today, Despite Solid Earnings. Here's Why.

Aug 9, 2024, 10:48 AM EDT - 5 months ago

Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst

Aug 8, 2024, 8:27 PM EDT - 5 months ago

Insulet Corporation (PODD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:07 PM EDT - 5 months ago

Insulet inventory pressures cloud annual revenue forecast raise

Aug 8, 2024, 4:01 PM EDT - 5 months ago

Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year

Jul 26, 2024, 7:08 AM EDT - 6 months ago

Insulet expects to beat revenue estimates on strong insulin pump demand

Jul 26, 2024, 6:00 AM EDT - 6 months ago

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

Jul 8, 2024, 6:00 AM EDT - 6 months ago

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Jun 21, 2024, 6:30 PM EDT - 7 months ago

Insulet's SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Jun 20, 2024, 6:05 AM EDT - 7 months ago

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Jun 20, 2024, 6:00 AM EDT - 7 months ago

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Jun 11, 2024, 4:27 PM EDT - 7 months ago

Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023

May 28, 2024, 6:00 AM EDT - 8 months ago

Insulet to Present at the Jefferies Global Healthcare Conference

May 9, 2024, 8:34 PM EDT - 9 months ago

Insulet Corporation (PODD) Q1 2024 Earnings Call Transcript

May 9, 2024, 5:51 PM EDT - 9 months ago

Insulet misses first-quarter profit estimates as marketing costs weigh

May 9, 2024, 4:01 PM EDT - 9 months ago

Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year

May 7, 2024, 6:00 AM EDT - 9 months ago

Insulet's 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth

Apr 3, 2024, 6:00 AM EDT - 10 months ago

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

Apr 3, 2024, 6:00 AM EDT - 10 months ago

Nadav Eiron Joins Crusoe as Senior Vice President of Cloud Engineering

Mar 20, 2024, 6:00 AM EDT - 10 months ago

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

Mar 8, 2024, 6:00 AM EST - 11 months ago

Insulet's Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

Mar 5, 2024, 6:00 AM EST - 11 months ago

Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Feb 22, 2024, 7:55 PM EST - 11 months ago

Insulet Corporation (PODD) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 4:07 PM EST - 11 months ago

Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)